Researchers have developed a powerful new tool that makes it easier to study the mix of cell types in human tissue, which is crucial for understanding diseases such as cancer.
A new risk prediction tool developed by the American Heart Association (AHA) estimated cardiovascular disease (CVD) risk in a diverse patient cohort more accurately than current models, according to a recent study published in Nature Medicine.
With the help of artificial intelligence (AI), an inexpensive test found in many doctors’ offices may soon be used to screen for hidden heart disease.
New University of Virginia School of Medicine research suggests an unexpected way doctors may be able to improve blood flow to the brain to battle Alzheimer’s and other neurodegenerative diseases.
When electrical activity travels across the brain, it moves like ripples on a pond. The motion of these “brain waves,” first observed in the 1920s, can now be seen more clearly than ever before thanks to instruments and techniques created by a Stanford-led team.
The recognition underscores FastWave’s rising prominence in intravascular lithotripsy, as the company expands its intellectual property portfolio and momentum in cardiovascular innovation.
Sculpteo has announced a collaboration with My Human Kit, a French association specialising in inclusive innovation in the design and manufacture of personalised, accessible, and sustainable prosthetics.
CVRx (Nasdaq:CVRX) announced today that CMS proposed to keep its Barostim implant procedure within a certain payment class.
ECG monitor is supporting research at Brigham and Women’s Hospital in Boston aimed at understanding and improving detection of postoperative atrial fibrillation (poAF). Preliminary findings, presented at Euroanaesthesia 2025 in Portugal, show that continuous cardiac rhythm monitoring for up to 14 days after cardiac surgery helped uncover cases of poAF that may have gone undetected during the hospital stay.
TWINSBURG, Ohio, July 15, 2025 /PRNewswire/ — Edgepark has recently expanded its portfolio to include the latest innovations from diabetes manufacturers, including the first-ever FDA-cleared yearlong continuous glucose monitor (CGM) system, and a glucose biosensor that can be purchased without a prescription.